| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/1996 | US5486463 TNF-muteins |
| 01/23/1996 | US5486461 Casein hydrolyzate and method for production of such casein hydrolyzate |
| 01/23/1996 | US5486456 Method of diagnosing ovarian, endometrial, and colon cancers with monoclonal antibodies OXA and OXB |
| 01/23/1996 | US5486453 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |
| 01/23/1996 | US5486351 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
| 01/23/1996 | CA1338002C Glycopeptide recovery process |
| 01/23/1996 | CA1337977C Method and materials for the microbial bioconversion of toluene and other phenyl compounds |
| 01/23/1996 | CA1337976C Insulin precursors |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001425A2 Assay for inhibitors of dp-1 and other dp proteins |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001321A1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001317A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | WO1996001274A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194169A1 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | CA2193091A1 Assay for inhibitors of dp-1 and other dp proteins |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/17/1996 | EP0692537A2 Recombinant gibberellin DNA and uses thereof |
| 01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
| 01/17/1996 | EP0692258A1 Periwinkle seed extract and composition containing it |
| 01/17/1996 | EP0692032A1 Suppressor of hiv replication and transcription |
| 01/17/1996 | EP0692031A1 Heterologous antigens in live cell vaccine strains |
| 01/17/1996 | EP0692028A1 Pharmaceuticals based on papillomaviruses |
| 01/17/1996 | EP0692026A1 A human t-cell receptor of the g-protein coupled receptor family |
| 01/17/1996 | EP0692025A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/17/1996 | EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484889 Plant protein useful for treating tumors and HIV infection |
| 01/16/1996 | US5484724 DNA encoding GLSI |
| 01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 01/16/1996 | US5484706 Immunoassay for analytes in samples using alkylating agents |
| 01/16/1996 | US5484591 Method for treating gram negative bacterial infections in humans |
| 01/16/1996 | CA1337936C Vibriolysin coupling process |
| 01/16/1996 | CA1337935C Antibiotic derived from bacillus subtilis strains ncib 12375, 12376 and 12616 and related strains |
| 01/11/1996 | WO1996000903A1 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 01/11/1996 | WO1996000787A1 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 01/11/1996 | WO1996000783A1 Antibodies which bind to insect gut proteins and their use |
| 01/11/1996 | WO1996000577A1 Agents affecting thrombosis hemostasis |
| 01/11/1996 | DE4423724A1 Kinetisch kontrolliertes Verfahren zur enzymatischen Herstellung von Peptiden Kinetically controlled process for the enzymatic production of peptides |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | DE19515310A1 Artificial hip ball joint |
| 01/11/1996 | CA2194163A1 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 01/11/1996 | CA2193859A1 Antibodies which bind to insect gut proteins and their use |
| 01/11/1996 | CA2190642A1 Agents affecting thrombosis and hemostasis |
| 01/10/1996 | EP0691406A1 Process for the preparation of superoxide dismutase by recombinant DNA-technology |
| 01/10/1996 | EP0691403A1 Family of primate IP-3-like hemapoietic growth factors |
| 01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
| 01/10/1996 | EP0691348A1 Immunogenic compositions prepared from adenylate cyclase of B. Parapertussis |
| 01/10/1996 | EP0690991A1 Novel anticoagulant cofactor activity |
| 01/10/1996 | EP0690987A1 Immunoassay for determination of cells |
| 01/10/1996 | EP0690918A1 Protein tyrosine phosphatase ptp-s31 |
| 01/10/1996 | EP0690917A1 Recombinant epstein-barr virus protein and its use in vaccine |
| 01/10/1996 | EP0690916A1 Novel pesticidal proteins and strains |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690914A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 01/10/1996 | EP0690913A1 Expression of heterologous polypeptides in halobacteria |
| 01/10/1996 | EP0690876A1 Protein kinases |
| 01/10/1996 | EP0690874A1 Materials and methods relating to proteins that interact with casein kinase i |
| 01/10/1996 | EP0690873A1 Growth differentiation factor-8 |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690726A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 01/10/1996 | EP0690724A1 Chlamydia vaccine and process |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690675A1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/10/1996 | EP0493433B1 Method for improving human monoclonal antibody production and cells used therein |
| 01/09/1996 | US5482928 Biocidal proteins |
| 01/09/1996 | US5482858 Polypeptide linkers for production of biosynthetic proteins |
| 01/09/1996 | US5482856 Production of chimeric antibodies by homologous recombination |
| 01/09/1996 | US5482853 Nuclear sequence for cellular genomes |
| 01/09/1996 | US5482850 Method for identifying anti-parasitic compounds |
| 01/09/1996 | US5482835 Methods of testing in yeast cells for agonists and antagonists of mammal G-protein coupled receptors |
| 01/09/1996 | US5482723 Streptococcus bacteria for milk |
| 01/09/1996 | US5482713 Equine herpesvirus recombinant poxvirus vaccine |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/04/1996 | WO1996000392A1 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 01/04/1996 | WO1996000297A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 01/04/1996 | WO1996000289A1 Protocadherin proteins and their uses |
| 01/04/1996 | WO1996000288A2 Class bi and ci scavenger receptors |
| 01/04/1996 | WO1996000242A1 Retinoic acid receptor epsilon |
| 01/04/1996 | WO1996000239A1 Method of isolating isolectins from mistletoe |
| 01/04/1996 | WO1996000084A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 01/04/1996 | WO1995033059A3 Receptor for oncostatin m |